ICOSA is a European intellectual property firm, founded in 2009, specializing in supporting stakeholders in the Health, Cosmetics, Food, Environment, and Tech industries.
ICOSA help companies and investors address intellectual property challenges by protecting, securing, and maximizing the value of their innovations worldwide (patents, trademarks, designs, contracts, etc.).

With a team of 90 multidisciplinary professionals, they combine technical expertise, business vision, and strategic insight to guide clients through every stage of their growth, from start-ups to multinational corporations.
Based in France and Belgium, ICOSA positions itself as a specialist in intellectual property strategy, a trusted partner at the heart of innovation ecosystems, and a key player in creating value across European and global markets.

Efor Group is a global leader in quality and regulatory compliance consulting for the Life Sciences industry. Founded in 2013, the company supports pharmaceutical, biotechnology, and medical device organizations in securing their manufacturing operations and accelerating the delivery of innovative therapies to patients.

With more than 3,000 experts across 18 countries, Efor provides end-to-end solutions covering Commissioning, Qualification and Validation (CQV), Quality Management, and Engineering Compliance. Its approach combines deep technical expertise with a strong understanding of regulatory requirements, enabling clients to ensure the reliability, safety, and compliance of their production systems throughout the entire product lifecycle.

Efor’s innovative model is based on flexible, modular, and tailor-made solutions designed to adapt to each client’s specific challenges, from early clinical phases to large-scale commercial manufacturing. By removing technical and regulatory barriers, the company helps reduce time-to-market while maintaining the highest standards of quality and patient safety.

Committed to sustainable growth, Efor integrates environmental and social responsibility into its operations and aims to become a global benchmark in Life Sciences consulting.